Video game approved by FDA for ADHD

Video game approved by FDA for ADHD, a new study reports. The FDA has formally granted marketing approval to the first game-based remedy. Built by Akili Interactive Labs, Inc., a video game known as EndeavorRx, is a non-drug therapy alternative for children aged 8-12 years old who have diagnosed with some type of ADHD. The primary video game-based treatment for attention deficit hyperactivity disorder (ADHD) authenticated by the US Food and Drug Administration (FDA).

It will be administered alongside other treatments, such as doctor-directed treatment, medications, and instructional strategies. ADHD is a recurrent neurodevelopmental disorder that is repeatedly first diagnosed in children and can last into adulthood.

About 4 million children aged six to 11 are affected by ADHD, the symptoms of which include trouble staying focused and paying attention and difficulty controlling conduct. The first-and-only prescribed therapy of its kind, this ADHD video game has made a way to make treatment pleasure, attainable, and virtual, which is a game-changer for the mental health domain.